Entimo AG is pleased to announce that Marc Jobert has joined the company’s Supervisory Board. Marc has extensive professional experience and expertise in clinical research and development, and he has successfully led companies through the challenges of technological and digital transformations. The board of shareholders elected Marc to this position unanimously during the annual shareholder meeting in June 2026.

“Marc and I are more than just namesakes. We have worked together in the past in very successful enterprise level projects. I know Marc as a person who combines vision with expertise to craft sustainable innovations.” said Marc Jantke, entimo CEO.

“Marc's wide-ranging experience through many different leading industry functions provides a valuable perspective. He will bring insights to his position on the board and contribute to the company's direction as a skilled advisor” added Sven Prasse, entimo COO.

"It is my pleasure and honor to be elected to Entimo's supervisory board. Entimo is a relevant player as a provider of enterprise software for regulated clinical research and development for more than 20 years. I am looking forward to working with the supervisory board, Marc and Sven to support the current diversification of entimo's portfolio of products and services," said Marc Jobert, Head of IT, Axolabs.

Marc Jobert brings more than 35 years of senior leadership experience in the pharmaceutical and CRO industries, with a strong focus on technology, digital transformation, and the translation of complex business requirements into effective IT strategies and solutions across the drug development lifecycle.

Marc began his career at Schering AG in Berlin before joining PAREXEL International, where he advanced to a series of senior technology leadership positions. As Chief Technology Officer, he led a five-year strategic digital transformation, driving the evolution of the company’s technology landscape in support of its global business.

He subsequently joined Abbott EPD as Head of Business Relationship Management, overseeing IT business relationship management and acting as a strategic technology partner to senior leadership across R&D, Clinical, Regulatory, Quality, Medical, and Safety/Pharmacovigilance. In this role, he contributed to strengthening alignment between business and IT, and to enhancing interoperability across the R&D systems landscape.

Since 2024, Marc has served as Head of IT at Axolabs, with responsibility for GxP-related IT across the company’s operations in Germany and the United States. His focus includes building standardized, resilient, and audit-ready IT environments across infrastructure, laboratory systems, manufacturing equipment, and instrument workstations, supporting GxP compliance, scalability, and business continuity.

With his extensive experience at the intersection of life sciences, technology, and business transformation, Marc brings a broad industry and technology perspective to his role on the Entimo Supervisory Board.